| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8735233 | Hepatobiliary & Pancreatic Diseases International | 2018 | 7 Pages |
Abstract
Sufficient desensitization for ABO-I living donor liver transplantation can be achieved using rituximab alone. This desensitization strategy does not affect the isoagglutinin titers, ABO-I-related complications and patient survival.
Related Topics
Health Sciences
Medicine and Dentistry
Hepatology
Authors
Eung Chang Lee, Seong Hoon Kim, Jae Ryong Shim, Sang-Jae Park,